These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19201814)

  • 1. Modulation of epidermal growth factor receptor binding to human airway smooth muscle cells by glucocorticoids and beta2-adrenergic receptor agonists.
    Kassel KM; Schulte NA; Toews ML
    Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L693-9. PubMed ID: 19201814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells.
    Eickelberg O; Roth M; Lörx R; Bruce V; Rüdiger J; Johnson M; Block LH
    J Biol Chem; 1999 Jan; 274(2):1005-10. PubMed ID: 9873044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells.
    Ediger TL; Danforth BL; Toews ML
    Am J Physiol Lung Cell Mol Physiol; 2002 Jan; 282(1):L91-8. PubMed ID: 11741820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.
    Kassel KM; Schulte NA; Parker SM; Lanik AD; Toews ML
    J Pharmacol Exp Ther; 2007 Oct; 323(1):109-18. PubMed ID: 17640953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticosteroids and β₂-adrenoceptor agonists synergize to inhibit airway smooth muscle remodeling.
    Dekkers BG; Pehlic A; Mariani R; Bos IS; Meurs H; Zaagsma J
    J Pharmacol Exp Ther; 2012 Sep; 342(3):780-7. PubMed ID: 22685341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle.
    Oltmanns U; Walters M; Sukkar M; Xie S; Issa R; Mitchell J; Johnson M; Chung KF
    Pulm Pharmacol Ther; 2008; 21(2):292-7. PubMed ID: 17692547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation.
    Nie M; Knox AJ; Pang L
    J Immunol; 2005 Jul; 175(1):478-86. PubMed ID: 15972682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids.
    Pang L; Knox AJ
    FASEB J; 2001 Jan; 15(1):261-269. PubMed ID: 11149914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement.
    Kassel KM; Wyatt TA; Panettieri RA; Toews ML
    Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L131-8. PubMed ID: 17993585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid- and protein kinase A-dependent transcriptome regulation in airway smooth muscle.
    Misior AM; Deshpande DA; Loza MJ; Pascual RM; Hipp JD; Penn RB
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):24-39. PubMed ID: 19059887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure.
    Nino G; Hu A; Grunstein JS; Grunstein MM
    J Allergy Clin Immunol; 2010 May; 125(5):1020-7. PubMed ID: 20392484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone rescues TGF-β1-mediated β
    Chung E; Ojiaku CA; Cao G; Parikh V; Deeney B; Xu S; Wang S; Panettieri RA; Koziol-White C
    Respir Res; 2020 Oct; 21(1):256. PubMed ID: 33032603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids ablate IL-1beta-induced beta-adrenergic hyporesponsiveness in human airway smooth muscle cells.
    Moore PE; Laporte JD; Gonzalez S; Moller W; Heyder J; Panettieri RA; Shore SA
    Am J Physiol; 1999 Nov; 277(5):L932-42. PubMed ID: 10564178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta2-Adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells.
    Futamura K; Orihara K; Hashimoto N; Morita H; Fukuda S; Sagara H; Matsumoto K; Tomita Y; Saito H; Matsuda A
    Int Arch Allergy Immunol; 2010; 152(4):353-61. PubMed ID: 20185927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
    Kaur M; Chivers JE; Giembycz MA; Newton R
    Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.
    Manetsch M; Rahman MM; Patel BS; Ramsay EE; Rumzhum NN; Alkhouri H; Ge Q; Ammit AJ
    PLoS One; 2013; 8(3):e59635. PubMed ID: 23533638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of airway smooth muscle alpha-actin expression by glucocorticoids.
    Goldsmith AM; Hershenson MB; Wolbert MP; Bentley JK
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L99-L106. PubMed ID: 16980374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.
    Lewis RJ; Chachi L; Newby C; Amrani Y; Bradding P
    J Immunol; 2016 Jan; 196(1):55-63. PubMed ID: 26608913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB.
    Baouz S; Giron-Michel J; Azzarone B; Giuliani M; Cagnoni F; Olsson S; Testi R; Gabbiani G; Canonica GW
    Int Immunol; 2005 Nov; 17(11):1473-81. PubMed ID: 16210331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
    Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
    PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.